Health Care/Hospital

Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab

SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the commencement of a proposed registered underwritten pu...

2021-02-06 06:27 9213

Hidrox(R), a proprietary olive polyphenols formulation may help in managing COVID-19 pandemic

HAYWARD, Calif., Feb. 6, 2021 /PRNewswire/ -- Oliphenol LLC, Hayward, California , announces the publication of a discovery focused upon the SARS-CoV-2-inactivating activity of Hidrox®, an olive polyphenols formulation for a potential treatment against SARS-CoV-2 infection. The Paper, "The SARS-C...

2021-02-06 00:17 2857

I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S.

SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced multiple clinical advancements for its proprieta...

2021-02-05 21:00 5606

111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services

SHANGHAI, Feb. 5, 2021 /PRNewswire/ -- On January 11, 2021, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, and Jilin Baiyi Doctor Group Management Co., Lt...

2021-02-05 19:00 5047

Thomson X Inks Strategic Partnership with Singapore-Based Startup Plano and Set Sights on Managing Myopia in Asia

SINGAPORE, Feb. 5, 2021 /PRNewswire/ -- Thomson X ("TX"), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the "Group"), today announced a strategic partnership with Plano Pte Ltd (" Plano"), a Singapore-based HealthTech startup. The collaboration will leverage on ...

2021-02-05 18:00 3143

iHerb holds "Happy Lunar New Year" themed sales event

HONG KONG, Feb. 5, 2021 /PRNewswire/ -- To add joy to every customer, iHerb officially open the theme of "Happy Lunar New Year!" with a considerable discount. Happy Lunar New Year! Discount: customers can get 8% discount only if the order full of ...

2021-02-05 17:34 3036

Report offers checkup on health of Chinese people in 2020

HANGZHOU, China, Feb. 5, 2021 /PRNewswire/ -- Over 60 percent of respondents held a positive attitude toward the prospects of China's healthcare system and the potential for technologies, a health report found. China Daily app and DX Doctor (DXY), a health information sharing platform, published...

2021-02-05 13:08 2407

TCAI physicians participate in clinical trial for potential life-saving device for patients with heart rhythm disorders

AUSTIN, Texas, Feb. 5, 2021 /PRNewswire/ -- Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation procedures safer for...

2021-02-05 12:20 2291

Sihuan Pharmaceutical (0460.HK) The sole agent of Letybo 100U China AI Listing Conference was successfully held

HONG KONG, Feb. 5, 2021 /PRNewswire/ -- Exclusively represented by Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange stock code: 0460), Letybo®100U, a type A botuli...

2021-02-05 11:32 4601

Boao Lecheng: A Miraculous Pioneer of Asian High-end Medical Tourism

HAIKOU, China, Feb. 5, 2021 /PRNewswire/ -- Recently, Boao Super Hospital performed an operation of transcatheter aortic valve replacement (TAVR) in conjunction with the use of the TriGUARD3TM Cerebral Embolic Protection Device (hereafter referred to as TriGUARD3). This is the first clinical appl...

2021-02-05 10:36 1817

IHME extends COVID-19 forecasts to June 1, predicting over 3.5 million deaths globally

Rapid vaccination rollout, mask wearing crucial to control spread SEATTLE, Feb. 5, 2021 /PRNewswire/ -- The latest COVID-19 forecasts from the Institute for Health Metrics and Evaluation at theUniversity of Washington School of Medicine predict more than 3.5 million deaths globally byJune 1. Th...

2021-02-05 10:09 2461

DFI Joins Hands with German ACL to Develop Substantial Business Opportunities in the Smart Medical Market

TAIPEI, Feb. 5, 2021 /PRNewswire/ -- DFI, a leading industrial computer manufacturer, has entered a strategic alliance with ACL, a well-known German medical IT hardware manufacturer, and will combine with DFI's 40 years of rich experience in industrial computers. ACL has been famous in the medica...

2021-02-05 09:00 2241

Introducing geneslim (tm), a new weight management innovation combining latest nutritional science, body contouring technology and genetics research

HONG KONG, Feb. 5, 2021 /PRNewswire/ -- geneslimtm, a new weight and health management program backed by latest nutritional science and genetics research, helps to manage weight and increases vitality for busy Hong Kongers. gene...

2021-02-05 08:08 1893

Thousands Join Global Call for Universal Access to Reproductive Health at 'Not Without FP' Virtual Forum

International leaders and experts advocate for rights-based family planning, examine threat COVID-19 poses to reproductive health BALTIMORE, Feb. 5, 2021 /PRNewswire/ -- More than 7,000 people attended this week's global online forum, "Not Without FP," to champion the important role family plann...

2021-02-05 07:13 1831

Global survey presented at the Digital Liver Cancer Summit 2021 reveals heavy toll of COVID-19 first wave on liver cancer care

GENEVA, Feb. 5, 2021 /PRNewswire/ -- The delays of screening programmes, diagnostic imaging and biopsies, cuts in the numbers of physicians available to treat liver cancer patients, cancellations of surgery, and a drop in the number of patients entered on clinical trials, were just some of the is...

2021-02-05 07:00 2275

Ortho Clinical Diagnostics Announces Closing of Full Over-Allotment Option from Initial Public Offering

RARITAN, N.J., Feb. 5, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) ("Ortho"), the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the cl...

2021-02-05 06:40 6617

I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China

SHANGHAI and GAITHERSBURG, Md., Feb. 4, 2021 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed in a phase 2 clinic...

2021-02-04 21:00 5015

Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries

TAIPEI, Feb.4, 2021 /PRNewswire/ -- Golden Biotechnology Corp.(TPEx:4132)("GoldenBiotech"), a leading Taiwanese biopharmaceutical company, announced that it has made two achievements for its Covid-19 new drug candidate Antroquinonol® (HOCENA®): receiving positive response after DMC review in Pha...

2021-02-04 20:30 1460

Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries

TAIPEI, Feb. 4, 2021 /PRNewswire/ -- Golden Biotechnology Corp.(TPEx:4132)("GoldenBiotech"), a leading Taiwanese biopharmaceutical company, announced that it has made two achievements for its Covid-19 new drug candidate Antroquinonol® (HOCENA®): receiving positive response after DMC review in Ph...

2021-02-04 18:41 1898

Mentice publishes the company's year-end report for the period January-December 2020

STOCKHOLM, Feb. 4, 2021 /PRNewswire/ -- Strong order intake and substantial improvement of the company's order book as well as operating cash flow Fourth quarter (October-December 2020)            * Order intake amounted to 73.1 (54.7) MSEK. * Net sales amounted to 45.9 (60.2) MSEK. * Ope...

2021-02-04 16:08 1427
1 ... 568569570571572573574 ... 810

Week's Top Stories